Clinical Trial Update: Evaluation of Copeptin in Patients With Cirrhosis and Ascites [NA]

View source ↗

Summary

Clinical trial evaluating the biomarker copeptin in patients with cirrhosis and ascites has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Cirrhotic Patients With Ascites | NA | Status: COMPLETED